Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

14.27
Delayed Data
As of Mar 27
 +0.74 / +5.47%
Today’s Change
7.70
Today|||52-Week Range
15.20
+44.43%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close13.53
Today’s open13.29
Day’s range13.06 - 14.37
Volume1,239,313
Average volume (3 months)1,776,587
Market cap$1.9B
Dividend yield--
Data as of 03/27/2017

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)-19.93%
Earnings growth (next 5 years)+7.12%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc+0.78+2.04%
ONCESpark Therapeutics I...+0.22+0.42%
AVXSAveXis Inc+1.38+1.84%
JUNOJuno Therapeutics In...+0.65+3.22%
Data as of 03/27/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts


Search for Jobs